Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (301-310 of 321) with videos related to

Pageof 33
Sort By:
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Nature Communications|September 21, 2019
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticlePhilip J M Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, et al.
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.
Nature Communications|August 11, 2021
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEMAleksandar Antanasijevic, Leigh M Sewall, Christopher A Cottrell, et al.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Nature Medicine|May 13, 2020
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersPrabhu S Arunachalam, Tysheena P Charles, Vineet Joag, et al.
The Journal of Experimental Medicine|September 5, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Pageof 33

Showing results (301-310 of 321) with videos related to

Sort By:
Pageof 33
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Nature Communications|September 21, 2019
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticlePhilip J M Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, et al.
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.
Nature Communications|August 11, 2021
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEMAleksandar Antanasijevic, Leigh M Sewall, Christopher A Cottrell, et al.
Cell|December 22, 2015
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing EpitopesSteven W de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Nature Communications|May 31, 2019
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequenceKwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
The Journal of Experimental Medicine|August 30, 2017
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivoMax Medina-Ramírez, Fernando Garces, Amelia Escolano, et al.
Nature Medicine|May 13, 2020
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titersPrabhu S Arunachalam, Tysheena P Charles, Vineet Joag, et al.
The Journal of Experimental Medicine|September 5, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodiesWilliam O Hahn, K Rachael Parks, Mingchao Shen, et al.
Pageof 33